Cargando…
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN Study
BACKGROUND: Warfarin is an anticoagulant medication proven effective in the initial treatment and secondary prevention of venous thromboembolism. Anti-Xa direct oral anticoagulants are alternatives to warfarin; however there is limited data assessing satisfaction after switching from warfarin to an...
Autores principales: | Hendriks, Thomas, McGregor, Scott, Rakesh, Shilpa, Robinson, Julie, Ho, Kwok M., Baker, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272044/ https://www.ncbi.nlm.nih.gov/pubmed/32497116 http://dx.doi.org/10.1371/journal.pone.0234048 |
Ejemplares similares
-
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021) -
Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2023) -
Optimal duration of anticoagulation in patients with venous thromboembolism
por: Prandoni, Paolo, et al.
Publicado: (2011) -
Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018) -
Extended anticoagulation after venous thromboembolism: should it be
done?
por: Fernandes, Caio J., et al.
Publicado: (2019)